|
|
|
| Research progress on post-stroke depression |
| CHEN Shun PANG Tao▲ |
| Department of Pharmacy, Changzheng Hospital of the Second Military Medical University, Shanghai 200433, China |
|
|
|
Abstract Post-stroke depression (PSD) is the most common mental health problem, accounting for approximately 33% of stroke survivors. PSD has a negative impact on post-stroke rehabilitation, leading to cognitive deficits and a significant increase in neurovascular recurrence. Biological and psychological factors have been shown to play an important role in PSD. Risk factors and predictors of PSD have been found to be of concern in screening and diagnosis, but no corresponding testing tools have been developed. According to the patient′s basic conditions and response characteristics, drug treatment should be selected, and the importance of psychotherapy also should be emphasized. This article is based on the existing research on PSD prediction, screening and treatment, and provides reference for future related research.
|
|
|
|
|
|
[1] Man SC，Hung BH，Ng RM，et al. A pilot controlled trial of a combination of dense cranial electroacupuncture stimulation and body acupuncture for post-stroke depression [J]. BMC Complement Altern Med，2014，14：255.
[2] Liu R，Yue Y，Jiang H，et al. A risk prediction model for post-stroke depression in Chinese stroke survivors based on clinical and socio-psychological features [J]. Oncotarget，2017，8（38）：62 891-62 899.
[3] Ayerbe L1，Ayis S，Wolfe CD，et al. Natural history，predictors and outcomes of depression after stroke： systematic review and meta-analysis [J]. Br J Psychiatry，2013，202（1）：14-21.
[4] Hackett ML，Anderson CS. Predictors of depression after stroke：a systematic review of observational studies [J]. Stroke，2005，36（10）：2296-2301.
[5] Loubinoux I，Kronenberg G，Endres M，et al. Post-stroke depression：mechanisms，translation and therapy [J]. J Cell Mol Med，2012，16（9）：1961-1969.
[6] Novick D，Kim S，Kaplanski G，et al. Interleukin-18，more than a Th1 cytokine [J]. Semin Immunol，2013，25（6）：439-448.
[7] Lenzi GL，Altieri M，Maestrini I. Post-stroke depression [J]. Rev Neurol（Paris），2008，164（10）：837-840.
[8] Villa RF，Ferrari F，Moretti A. Post-stroke depression：Mechanisms and pharmacological treatment [J]. Pharmacol Ther，2018，184：131-144.
[9] Guiraud V，Gallarda T，Calvet D，et al. Depression predictors within six months of ischemic stroke：The DEPRESS Study [J]. Int J Stroke，2016，11（5）：519-525.
[10] de Man-van Ginkel JM，Hafsteinsdóttir TB，Lindeman E，et al. In-hospital risk prediction for post-stroke depression：development and validation of the Post-stroke Depression Prediction Scale [J]. Stroke，2013，44（9）：2441-2445.
[11] Shi Y，Yang D，Zeng Y，et al. Risk Factors for Post-stroke Depression：A Meta-analysis [J]. Front Aging Neurosci，2017，9：218.
[12] Winstein CJ，Stein J，Arena R，et al. Guidelines for Adult Stroke Rehabilitation and Recovery：A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association [J]. Stroke，2016， 47（6）：98-169.
[13] Meader N，Moe-Byrne T，Llewellyn A，et al. Screening for poststroke major depression： a meta-analysis of diagnostic validity studies [J]. J Neurol Neurosurg Psychiatry，2014，85（2）：198-206.
[14] Yue Y，Jiang H，Liu R，et al. Towards a multi protein and mRNA expression of biological predictive and distinguish model for post stroke depression [J]. Oncotarget，2016，7（34）：54329-54338.
[15] Cao Y，Linden P，Shima D，et al. In vivo angiogenic activity and hypoxia induction of heterodimers of placenta growth factor/vascular endothelial growth factor [J]. J Clin Invest，1996，98（11）：2507-2511.
[16] Fischer C，Mazzone M，Jonckx B，et al. FLT1 and its ligands VEGFB and PlGF： drug targets for anti-angiogenic therapy? [J]. Nat Rev Cancer，2008，8（12）：942-956.
[17] McCann SK，Cramond F，Macleod MR，et al. Systematic Review and Meta-Analysis of the Efficacy of Interleukin-1 Receptor Antagonist in Animal Models of Stroke：an Update [J]. Transl Stroke Res，2016，7（5）：395-406.
[18] Craft TK，DeVries AC. Role of IL-1 in poststroke depressive-like behavior in mice [J]. Biol Psychiatry，2006， 60（8）：812-818.
[19] Ramasubbu R，Tobias R，Buchan AM，et al. Serotonin transporter gene promoter region polymorphism associated with poststroke major depression [J]. J Neuropsychiatry Clin Neurosci，2006，18（1）：96-99.
[20] Deng L，Qiu S，Yang Y，et al. Efficacy and tolerability of pharmacotherapy for post-stroke depression：a network meta-analysis [J]. Oncotarget，2018，9（34）：23718-23728.
[21] Lipsey JR，Robinson RG. Nortriptyline for post-stroke depression [J]. Lancet，1984，1（8380）：803.
[22] DeVane CL，Markowitz JS. Avoiding psychotropic drug interactions in the cardiovascular patient [J]. Bull Menninger Clin，2000，64（1）：49-59.
[23] Starkstein SE，Mizrahi R，Power BD. Antidepressant therapy in post-stroke depression [J]. Expert Opin Pharmacother，2008，9（8）：1291-1298.
[24] Xu XM，Zou DZ，Shen LY，et al. Efficacy and feasibility of antidepressant treatment in patients with post-stroke depression [J]. Medicine（Baltimore），2016，95（45）：5349.
[25] Kilic FS，Ozatik Y，Kaygisiz B，et al. Acute antidepressant and anxiolytic effects of simvastatin and its mechanisms in rats [J]. Neurosciences（Riyadh），2012，17（1）：39-43.
[26] Reiner Z，Catapano AL，De Backer G，et al. ESC/EAS Guidelines for the management of dyslipidaemias：the Task Force for the management of dyslipidaemias of the European Society of Cardiology （ESC）and the European Atherosclerosis Society（EAS） [J]. Atherosclerosis，2011， 217：S1-S44.
[27] Patrick RP，Ames BN. Vitamin D hormone regulates serotonin synthesis. Part 1：relevance for autism [J]. Faseb J，2014，28（6）：2398-2413.
[28] Ganji V，Milone C，Cody MM，et al. Serum vitamin D concentrations are related to depression in young adult US population：the Third National Health and Nutrition Examination Survey [J]. Int Arch Med，2010，3：29.
[29] Zittermann A，Dembinski J，Stehle P. Low vitamin D status is associated with low cord blood levels of the immunosuppressive cytokine interleukin-10 [J]. Pediatr Allergy Immunol，2004，15（3）：242-246.
[30] Buell JS，Dawson-Hughes B. Vitamin D and neurocognitive dysfunction：preventing "D"ecline? [J]. Mol Aspects Med，2008，29（6）：415-422.
[31] Song C，Wang H. Wang. Cytokines mediated inflammation and decreased neurogenesis in animal models of depression [J]. Prog Neuropsychopharmacol Biol Psychiatry，2011，35（3）：760-768.
[32] Wang Q，Zhu Z，Liu Y，et al. Relationship between serum vitamin D levels and inflammatory markers in acute stroke patients [J]. Brain Behav，2018，8（2）：e00885.
[33] Wilson KC，Mottram PG，Vassilas CA. Psychotherapeutic treatments for older depressed people [J]. Cochrane Database Syst Rev，2008（1）：CD004853.
[34] Kootker JA，Fasotti L，Rasquin SM，et al. The effectiveness of an augmented cognitive behavioural intervention for post-stroke depression with or without anxiety （PSDA）：the Restore 4 Stroke-PSDA trial [J]. BMC Neurol，2012，12：51.
[35] Rasquin SM，Van De Sande P，Praamstra AJ，et al. Cognitive-behavioural intervention for depression after stroke：five single case studies on effects and feasibility [J]. Neuropsychol Rehabil，2009，19（2）：208-222.
[36] Shoshani Helvitz I. Bibliotherapy as a clinical tool and its applications in diagnosis，treatment and teaching medicine [J]. Harefuah，2016，155（12）：770-773.
[37] Eum Y，Yim J. Literature and art therapy in post-stroke psychological disorders [J]. Tohoku J Exp Med，2015， 235（1）：17-23.
[38] Miller KK，Combs SA，Van Puymbroeck M，et al. Fatigue and pain： relationships with physical performance and patient beliefs after stroke [J]. Top Stroke Rehabil，2013，20（4）：347-355.
[39] Eum Y，Yim J，Choi W. Elderly health and literature therapy：a theoretical review [J]. Tohoku J Exp Med，2014， 232（2）：79-83.
[40] Geretsegger M，Holck U，Gold C. Randomised controlled trial of improvisational music therapy′s effectiveness for children with autism spectrum disorders（TIME-A）：study protocol [J]. BMC Pediatr，2012，12：2.
[41] Baker F，Wigram T，Gold C. The effects of a song-singing programme on the affective speaking intonation of people with traumatic brain injury [J]. Brain Inj，2005，19（7）：519-528.
[42] Nie J，Yang X. Modulation of Synaptic Plasticity by Exercise Training as a Basis for Ischemic Stroke Rehabilitation [J]. Cell Mol Neurobiol，2017，37（1）：5-16.
[43] Hackett ML，Anderson CS，House A，et al. Interventions for preventing depression after stroke [J]. Cochrane Database Syst Rev，2008（3）：CD003689.
[44] Liu Q，Wang X，Wang Y，et al. Association between marriage and outcomes in patients with acute ischemic stroke [J]. J Neurol，2018，265（4）：942-948. |
|
|
|
